The Complementary Role of FEV6 in Bronchodilator Reversibility Test for the Old Age |
Kim, Sae Hee
(Department of Internal Medicine, Eulji University School of Medicine)
Lee, Yang Deok (Department of Internal Medicine, Eulji University School of Medicine) Lee, Jung Yun (Department of Internal Medicine, Eulji University School of Medicine) Cho, Yong Seon (Department of Internal Medicine, Eulji University School of Medicine) Na, Dong Jip (Department of Internal Medicine, Eulji University School of Medicine) Han, Min Soo (Department of Internal Medicine, Eulji University School of Medicine) |
1 | Killian KJ, Summers E, Watson RM, O'Byrne PM, Jones NL, Campbell EJ. Factors contributing to dyspnoea during bronchoconstriction and exercise in asthmatic subjects. Eur Respir J 1993:6:1004-10 |
2 | American Thoracic Society. Standardization of Spirometry, 1994 update. Am J Respir Crit Care Med 1995:152:1107-36 DOI ScienceOn |
3 | Pellegrino R, Rodarte JR, Brusasco V. Assessing the reversibility of airway obstruction. Chest 1998:114: 1607-12 DOI |
4 | Lorber DB, Kaltenborn W, Burrows B. Responses to isoproterenol in a general population sample. Am Rev Respir Dis 1978:118:855-61 |
5 | Dales RE, Spitzer WO, Tousignant P, Schechter M, Suissa S. Clinical interpretation of airway response to a bronchodilator: epidemiologic considerations. Am Rev Respir Dis 1988:138:317-20 DOI ScienceOn |
6 | Vandevoorde J, Verbanck S, Schuermans D, Kartounian J, Vincken W. Obstructive and restrictive spirometric patterns: fixed cut-offs for FEV1/FEV6 and FEV6. Eur Respir J 2006:27:378-83 DOI ScienceOn |
7 | Demir T, Ikitimur HD, Koc N, Yildirim N. The role of FEV6 in the detection of airway obstruction. Respir Med 2005:99:103-6 DOI ScienceOn |
8 | Nowak RM, Pensler MI, Sarkar DD, Anderson JA, Kvale PA, Ortiz AE, et al. Comparison of peak expiratory flow and FEV1 admission criteria for acute bronchial asthma. Ann Emerg Med 1982:11:64-9 DOI ScienceOn |
9 | Dow L. Asthma in older people. Clin Exp Allergy 1998:28:195-202 DOI ScienceOn |
10 | Eaton T, Withy S, Garrett JE, Mercer J, Whitlock RM, Rea HH. Spirometry in primary care practice: the importance of quality assurance and the impact of spirometry workshops. Chest 1999:116:416-23 DOI |
11 | Anthonisen NR, Wright EC. Bronchodilator response in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986:133:814-9 |
12 | Killian KJ, Watson R, Otis J, St Amand TA, O'Byrne PM. Symptom perception during acute bronchoconstriction. Am J Respir Crit Care Med 2000:162:490-6 DOI ScienceOn |
13 | Enright RL, Connett JE, Bailey WC. The FEV1/FEV6 predicts lung function decline in adult smokers. Respir Med 2002:96:444-9 DOI ScienceOn |
14 | Kendrick AH, Higgs CM, Whitfield MJ, Laszlo G. Accuracy of perception of severity of asthma: patients treated in general practice. BMJ 1993:307:422-4 DOI |
15 | Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005:26:319-38 DOI ScienceOn |
16 | Sourk RL, Nugent KM. Bronchodilator testing: confidence intervals derived from placebo inhalations. Am Rev Respir Dis 1983:128:153-7 DOI |
17 | Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J 2005:26:948-68 DOI ScienceOn |
18 | Swanney MP, Beckert LE, Frampton CM, Wallace LA, Jensen RL, Crapo RO. Validity of the American Thoracic Society and other spirometric algorithms using FVC and forced expiratory volume at 6 s for predicting a reduced total lung capacity. Chest 2004:126:1861-6 DOI |
19 | Stoller JK, Buist AS, Burrows B, Crystal RG, Fallat RJ, McCarthy K, et al. Quality control of spirometry testing in the registry for patients with severe alpha1-antitrypsin deficiency: alpha1-Antitrypsin Deficiency Registry Study Group. Chest 1997:111:899-909 DOI |
20 | Akpinar-Elci M, Fedan KB, Enright PL. FEV6 as a surrogate for FVC in detecting airways obstruction and restriction in the workplace. Eur Respir J 2006:27:374-7 DOI ScienceOn |